LENZ Therapeutics Secures $30 Million Through Private Share Sale
Company Announcements

LENZ Therapeutics Secures $30 Million Through Private Share Sale

LENZ Therapeutics (LENZ) has issued an announcement.

LENZ Therapeutics, Inc. has struck a deal with Ridgeback Capital Investment, L.P. for a private sale of over 1.5 million shares at $19 each, aiming to raise around $30 million. The shares, which are not yet registered under U.S. securities laws, are expected to be sold by July 17, 2024, with conditions. Additionally, LENZ Therapeutics plans to file for a resale registration of these shares with the SEC within 60 days post-closing, ensuring compliance and resale ability for the investor. The announcement was made public via a press release on July 15, 2024.

For a thorough assessment of LENZ stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyLenz Therapeutics, Corxel Pharmaceuticals report topline data from JX07001 trial
TheFlyOne new option listing and ten option delistings on October 21st
TheFlyLenz Therapeutics announces FDA acceptance of NDA for LNZ100
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App